Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 118141
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.118141
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.118141
Table 4 Association of FokI genotype with clinical characteristic, n (%)/mean ± SD
| Variables | FF (n = 77) | Ff (n = 108) | ff (n = 118) | P value |
| Male | 48 (62.34) | 70 (64.81) | 72 (61.02) | 0.838 |
| Age (years) | 52.62 ± 11.98 | 54.56 ± 12.34 | 52.19 ± 11.91 | 0.318 |
| Body mass index (kg/m2) | 22.32 ± 3.25 | 22.68 ± 3.58 | 23.16 ± 3.20 | 0.218 |
| Systolic blood pressure (mmHg) | 116.85 ± 6.22 | 115.95 ± 5.37 | 117.05 ± 5.01 | 0.290 |
| Diastolic blood pressure (mmHg) | 76.12 ± 4.39 | 76.28 ± 4.50 | 76.84 ± 4.70 | 0.492 |
| Serum uric acid (μmol/L) | 340.98 ± 81.86 | 346.95 ± 91.15 | 356.91 ± 100.89 | 0.473 |
| Total cholesterol (mmol/L) | 4.68 ± 1.02 | 4.70 ± 1.04 | 4.58 ± 1.19 | 0.702 |
| Triglycerides (mmol/L) | 2.07 ± 2.13 | 2.17 ± 1.81 | 2.41 ± 2.24 | 0.471 |
| Low-density lipoprotein cholesterol (mmol/L) | 2.80 ± 0.82 | 2.82 ± 0.93 | 2.72 ± 1.10 | 0.742 |
| High-density lipoprotein cholesterol (mmol/L) | 1.19 ± 0.42 | 1.13 ± 0.39 | 1.07 ± 0.36 | 0.100a |
| Serum 25-hydroxy vitamin D (nmol/L) | 59.08 ± 24.46 | 57.89 ± 18.87 | 54.61 ± 16.56 | 0.244 |
| Fasting plasma glucose (mmol/L) | 7.16 ± 3.15 | 7.06 ± 3.01 | 7.57 ± 2.64 | 0.382 |
| Neutrophil-to-lymphocyte ratio | 1.60 ± 0.53 | 1.72 ± 0.81 | 1.84 ± 0.81 | 0.073 |
| Platelet-to-lymphocyte ratio | 110.61 ± 40.27 | 113.48 ± 42.82 | 113.26 ± 44.36 | 0.885 |
| Systemic immune-inflammation index | 351.10 ± 156.80 | 392.70 ± 234.59 | 397.65 ± 234.66 | 0.291 |
- Citation: Liu ZH, Ran ZQ, Yang R, Chen LX, Wang ZZ, Li YY, Han R. Vitamin D, vitamin D receptor FokI polymorphism, and diabetic retinopathy: A case-control study in Kunming, China. World J Diabetes 2026; 17(5): 118141
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/118141.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.118141